US Patent 9597299 Method for treating gefitinib-resistant non-small-cell lung cancer
Patent 9597299 was granted and assigned to Macau University of Science and Technology on March, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9597299 Method for treating gefitinib-resistant non-small-cell lung cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.